Cargando…

Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity

BACKGROUND: Infusion of second generation autologous CD19-targeted chimeric antigen receptor (CAR) T cells in patients with R/R relapsed/refractory B-cell lymphoma (BCL) is affected by inflammatory complications, such as Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Current literat...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Matteis, Serena, Dicataldo, Michele, Casadei, Beatrice, Storci, Gianluca, Laprovitera, Noemi, Arpinati, Mario, Maffini, Enrico, Cortelli, Pietro, Guarino, Maria, Vaglio, Francesca, Naddeo, Maria, Sinigaglia, Barbara, Zazzeroni, Luca, Guadagnuolo, Serafina, Tomassini, Enrica, Bertuccio, Salvatore Nicola, Messelodi, Daria, Ferracin, Manuela, Bonafè, Massimiliano, Zinzani, Pier Luigi, Bonifazi, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886226/ https://www.ncbi.nlm.nih.gov/pubmed/36726971 http://dx.doi.org/10.3389/fimmu.2022.1058126

Ejemplares similares

Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy
por: De Matteis, Serena, et al.
Publicado: (2022)

Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients
por: Storci, Gianluca, et al.
Publicado: (2023)

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
por: Maffini, Enrico, et al.
Publicado: (2022)

Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review
por: Pensato, Umberto, et al.
Publicado: (2022)

Correction to: Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review
por: Pensato, Umberto, et al.
Publicado: (2022)

Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study
por: Bonifazi, Francesca, et al.
Publicado: (2018)

Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience
por: Casadei, Beatrice, et al.
Publicado: (2021)

The role of extracellular DNA in COVID-19: Clues from inflamm-aging
por: Storci, Gianluca, et al.
Publicado: (2021)

Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity
por: Pensato, Umberto, et al.
Publicado: (2021)

Brain dysfunction in COVID‐19 and CAR‐T therapy: cytokine storm‐associated encephalopathy
por: Pensato, Umberto, et al.
Publicado: (2021)

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy
por: Fabrizio, Vanessa A., et al.
Publicado: (2022)

P405: IN VITRO RESPONSE TO BCL-2 INHIBITION IN PEDIATRIC B PRECURSOR ALL WITH HIGH RISK CYTOGENETICS
por: Gottardi, Francesca, et al.
Publicado: (2023)

Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma
por: Suryadevara, Carter M., et al.
Publicado: (2018)

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy
por: Nissani, Abraham, et al.
Publicado: (2021)

Cancer Site-Specific Multiple microRNA Quantification by Droplet Digital PCR
por: Laprovitera, Noemi, et al.
Publicado: (2018)

Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation
por: Bonifazi, Francesca, et al.
Publicado: (2020)

Selective CD28 blockade impacts T cell differentiation during homeostatic reconstitution following lymphodepletion
por: Habib, Jakob G., et al.
Publicado: (2023)

Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma
por: Sidana, Surbhi, et al.
Publicado: (2023)

Are Induced Pluripotent Stem Cells a Step towards Modeling Pediatric Leukemias?
por: Bertuccio, Salvatore Nicola, et al.
Publicado: (2022)

P53. Effect of lymphodepletion and tumour on host and reconstituted regulatory T-cells in a model of murine melanoma
por: Kovács, J, et al.
Publicado: (2014)

NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus
por: Del Coco, Laura, et al.
Publicado: (2019)

ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution
por: Baccelli, Francesco, et al.
Publicado: (2023)

The p53 codon 72 proline allele is endowed with enhanced cell-death inducing potential in cancer cells exposed to hypoxia
por: Sansone, P, et al.
Publicado: (2007)

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8(+) T cells
por: Gattinoni, Luca, et al.
Publicado: (2005)

PTPN22 Acts in a Cell Intrinsic Manner to Restrict the Proliferation and Differentiation of T Cells Following Antibody Lymphodepletion
por: Knipper, Johanna A., et al.
Publicado: (2020)

Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy
por: Schroeder, Brett A, et al.
Publicado: (2020)

Convalescent-anti-sars-cov-2-plasma/rituximab/unspecified steroids: Fever and lymphodepletion: 2 case reports
Publicado: (2021)

Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment
por: Marquard, Franziska, et al.
Publicado: (2023)

Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes
por: Bonafè, Massimiliano, et al.
Publicado: (2020)

Eradicating tumor in a recurrent cervical cancer patient with autologous tumor-infiltrating lymphocytes and a modified lymphodepleting regimen
por: Guo, Jing, et al.
Publicado: (2022)

Anti-Gr-1 Antibody Provides Short-Term Depletion of MDSC in Lymphodepleted Mice with Active-Specific Melanoma Therapy
por: Rose, Peter, et al.
Publicado: (2022)

Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma
por: Acosta-Medina, Aldo A., et al.
Publicado: (2023)

Cancer of Unknown Primary: Challenges and Progress in Clinical Management
por: Laprovitera, Noemi, et al.
Publicado: (2021)

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD
por: He, Fiona, et al.
Publicado: (2016)

Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells
por: Tanaka, Tomohiro, et al.
Publicado: (2017)

Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy
por: Dawicki, Wojciech, et al.
Publicado: (2020)

Lymphodepletion chemotherapy revitalizes chimeric antigen receptor T cells contributing to regression of relapsed B-cell lymphoma: A case report
por: Liang, Zuyu, et al.
Publicado: (2020)

Response to: Letter to the Editor on “Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev” by Eugenia Quiros-Roldan, Giorgio Biasiotto and Isabella Zanella
por: Prattichizzo, Francesco, et al.
Publicado: (2021)

Role of CBL Mutations in Cancer and Non-Malignant Phenotype
por: Leardini, Davide, et al.
Publicado: (2022)

Subcortical Myoclonus in Coronavirus Disease 2019: Comprehensive Evaluation of a Patient
por: Muccioli, Lorenzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rroa2c5al7o02ur19pjnotj9j8